CD40LG and Hepatitis: In contrast with some published literature, where older age is a risk factor for complications and severe hepatitis [4, 29], in our cohort, the median age of patients with severe hepatitis was lower than that of patients with HAV-IgM positivity with no signs of a severe course (36/31.5 vs. 63 years, p < 0.001).